GLP-1 medications have reshaped daily routines for millions of people. Their effects now extend into vacation planning and travel habits.
The New York Times is asking readers to share how these drugs have influenced their trips. The publication seeks firsthand accounts from travelers using the medication.
GLP-1 drugs, including Ozempic and Wegovy, curb appetite and regulate blood sugar. Users often report eating less and drinking less alcohol while traveling.
Those changes can alter how people choose destinations and dining experiences. Some travelers may prioritize access to healthy food or medical care abroad.
Airline meals, cruise buffets, and resort dining often revolve around indulgence. GLP-1 users may find these settings less appealing or more difficult to navigate.
Long flights and time zone changes can also affect medication schedules. Travelers must plan ahead to keep doses on track while abroad.
The Times invitation signals a broader cultural shift in travel. Drug-induced appetite changes may influence tourism spending and hospitality offerings.
Readers interested in sharing their stories can respond to the Times directly. Their experiences could shape future coverage of health and travel.
